 STATEN ISLAND, N.Y., July 28, 2021 PRNewswire -- Acurx Pharmaceuticals, Inc. NASDAQ: ACXP Acurx or the Company, a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will release its 2021 second quarter financial results on Tuesday, August 17, 2021, at 8:30 am ET before the U.S. financial markets open. 